Company:  ULTRAGENYX PHARMACEUTICAL ... (RARE)
Form Type:  4
Filing Date:  11/8/2018 
CIK:  0001515673 
Address:  60 LEVERONI COURT 
City, State, Zip:  NOVATO, California 94949 
Telephone:  415-483-8800 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$50.99  
Change: 
0.26 (0.51%)  
Trade Time: 
Nov 20  
Market Cap: 
$2.58B
Trade RARE now with 

© 2018  
Description of Business
We are a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. We target diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no currently approved therapies. Since our inception in 2010, we have in-licensed potential treatments for multiple rare genetic disorders. Our strategy, which is predicated upon time- and cost-efficient drug development, allows us to pursue multiple programs in parallel with the goal of delivering safe and effective therapies to patients with the utmost urgency. Our approved product and current product candidate pipeline have been either in-licensed from academic institutions or derived from partnerships with other pharmaceutical companies.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES